有分类诊断意义的辐射生物剂量计。
结论MN法简便快速，结果准确，是除染色体畸变分析之外又一种可靠的生物剂量计。
Conclusion MN assay is simple, quick and accurate. It is a reliable biodosimetry in addition to chromosome aberration analysis.
结论T CR基因突变作为一种有潜力的生物剂量计可能用于近期辐射照射生物剂量的估算。
Conclusion It is suggested that TCR gene mutation, which served as a potential biological dosimeter, may be applied for the estimation of biological dose for recent radiation exposure.
血型糖蛋白A（GPA）基因突变频率在作为生物剂量计及癌的风险预测方面最大的缺陷在于个体差异大。
The prominent disadvantage of using GPA mutation frequency as biodosimeter and cancer risk predictor is the significant individual differences.
血型糖蛋白A（GPA）基因突变频率在作为生物剂量计及癌的风险预测方面最大的缺陷在于个体差异大。
The prominent disadvantage of using GPA mutation frequency as biodosimeter and cancer risk predictor is the significant individual differences.
应用推荐